Filociclovir

DB12438InvestigationalSmall molecule

Filociclovir is under investigation in clinical trial NCT01433835 (Safety and Pharmacokinetics of Single Oral Doses of Filociclovir in Healthy Volunteers).

Mechanism: Pharmacologically active on DNA polymerase catalytic subunit
Curator reviewed
Formula / weight: C₁₁H₁₃N₅O₃ · 263.257 g/mol (avg)
Code names: MBX-400 · ZSM-162 · ZSM-I 62

Resolves to

Compound

UNIIEAO0TD9B13CAS632325-71-4ChEMBLCHEMBL265948PubChem3006048

Structure

InChIKeyKMUNHOKTIVSFRA-KXFIGUGUSA-NSMILESNC1=NC2=C(N=CN2\C=C2\CC2(CO)CO)C(=O)N1

Targets

P08546UL54

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Filociclovir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account